Temporary interruption of endocrine therapy in women with endocrine-responsive breast cancer did not affect cancer outcomes
1. The 3-year incidence of breast cancer in the study group was 8.9% compared to 9.2% in the control group ...
1. The 3-year incidence of breast cancer in the study group was 8.9% compared to 9.2% in the control group ...
Click to read this study in The Lancet Oncology.
Click to read this study in the Journal of Clinical Oncology.
Click to read this study in The Lancet Oncology.
Click to read the study in Clinical Cancer Research.
Click to read the study in the European Journal of Cancer.
Click to read the study in The Lancet Oncology.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.